# US 2026/0043793 A1 · Microfluidic cell spheroids and organoids culture insert for disease modeling and screening of therapeutics

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0043793 A1
- Document ID: US20260043793A1
- Status: Published application
- Kind: A1
- Application number: 19/100,229
- Filed: 2023-08-03
- Published: 2026-02-12
- Earliest claimed: 2022-08-03
- Assignees: Apricell Biotechnology Inc.
- Applicants: Apricell Biotechnology Inc.
- Inventors: Amir SEYFOORI; Mohsen AKBARI
- Web page: https://patentgrep.com/patent/US20260043793A1

## CPC

- G01N 33/5088: {of vertebrates}
- C12M 23/12: {Well or multiwell plates (C12M25/04 takes precedence)}
- C12M 23/16: {Microfluidic devices; Capillary tubes (integrated microfluidic structures B01L3/5027; microreactors B01J19/0093)}
- C12M 23/34: {Internal compartments or partitions}
- C12M 29/00: {Means for introduction, extraction or recirculation of materials, e.g. pumps (pumps per se F04B)}
- C12N 5/0622: {Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells}
- C12N 5/0676: {Pancreatic cells}
- C12N 5/0682: {Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells (oocytes C12N5/0609)}
- C12N 5/0693: {Tumour cells; Cancer cells}
- G01N 33/5082: {Supracellular entities, e.g. tissue, organisms}
- C12N 5/0012: {Cell encapsulation}
- C12N 2502/1323: Adult fibroblasts
- C12N 2502/22: pancreatic cells
- C12N 2513/00: 3D culture
- G01N 2500/10: involving cells
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

A microfluidic device is provided for culturing cell spheroids or organoids and therapeutics screening, the microfluidic device comprising a shell and an at least one sector, the shell comprising a multiplicity of segments, each segment defined by a center point, an outer wall, and radially extending walls that radiate from the center point to the outer wall, the sector retained in the segment and comprising a plurality of microwells, a loading well which is in elevated relationship with the plurality of microwells, a plurality of micro-troughs which extend between the loading well and the plurality of microwells, such that each microwell is in fluid communication with the loading well via a micro-trough, a delivery port, and a plurality of delivery troughs which extend between the delivery port and the plurality of microwells such that each microwell is in fluid communication with the delivery port via a delivery trough.

## Claims

### Claim 1

A microfluidic device for use with a multi-well culture plate, for culturing cell spheroids or organoids for drug screening, the microfluidic device including at least one sector, each sector comprising: an outer edge; a plurality of microwells; a loading well which is in elevated relationship with the plurality of microwells; a plurality of micro-troughs which extend between the loading well and the plurality of microwells, such that each microwell is in fluid communication with the loading well via a micro-trough; a delivery port; and a plurality of delivery troughs which extend between the delivery port and the plurality of microwells such that each microwell is in fluid communication with the delivery port via a delivery trough.

### Claim 2 (depends on 1)

The microfluidic device of claim 1, further comprising a multiplicity of segments, each segment defined by a center point and radially extending walls that radiate from the center point to the outer wall, the sector retained in the segment.

### Claim 3 (depends on 2)

The microfluidic device of claim 2, each segment further comprising an inner wall disposed between the outer edge and the center point to define a second delivery port.

### Claim 4 (depends on 3)

The microfluidic device of claim 3, each segment further comprising a second delivery trough which extends between the second delivery port and the microwell such that the second delivery port and each microwell are in fluid communication.

### Claim 5 (depends on 4)

The microfluidic device of claim 4, wherein the sector is comprised of a biocompatible and transparent hydrogel.

### Claim 6 (depends on 5)

The microfluidic device of claim 5, wherein each segment further comprises a pool which is disposed below the microwells.

### Claim 7 (depends on 1)

The microfluidic device of claim 1 wherein the sector is comprised of a biocompatible rigid plastic polymer.

### Claim 8

(canceled)

### Claim 9 (depends on 1)

The microfluidic device of claim 1, wherein the radially extending walls are three-dimensionally printed in a well of the multi-well culture plate.

### Claim 10

A microfluidic device for culturing cell spheroids or organoids and screening of therapeutics, the microfluidic device comprising: at least one sector, the sector including at least one cell spheroids or organoid forming module and a first delivery module, the first delivery module in fluid communication with the cell spheroids or organoid forming module; and an outer shell which retains the sector, wherein the outer shell includes a second delivery module which is in fluid communication with the cell spheroids or organoid forming module, the microfluidic device configured for retention in a well of a culture plate.

### Claim 11 (depends on 10)

The microfluidic device of claim 10, wherein the cell spheroids or organoid forming module includes a plurality of microwells, a loading well which is in elevated relationship with the plurality of microwells, a plurality of micro-troughs which extend between the loading well and the plurality of microwells, such that each microwell is in fluid communication with the loading well via a micro-trough.

### Claim 12 (depends on 11)

The microfluidic device of claim 11, wherein the first delivery module includes a delivery port, and a plurality of delivery troughs which extend between the delivery port and the plurality of microwells such that each microwell is in fluid communication with the delivery port via a delivery trough.

### Claim 13

(canceled)

### Claim 14 (depends on 12)

The microfluidic device of claim 12, wherein the second delivery module includes a second delivery port, and a delivery microchannel which extends between the second delivery port and the first delivery module such that the second deliver port is in fluid communication with the first delivery module.

### Claim 15 (depends on 14)

The microfluidic device of claim 14, wherein the sector comprises at least one hydrogel.

### Claim 16 (depends on 15)

The microfluidic device of claim 15 further comprising a pool, which is in indirect fluid communication with at least one microwell.

### Claim 17 (depends on 16)

The microfluidic device of claim 16, wherein the pool is disposed below at least one microwell.

### Claim 18

A method of screening at least two therapeutics, the method comprising: selecting a microfluidic device, the microfluidic device comprising at least one sector, the sector including at least one cell spheroids or organoid forming module and a first delivery module, the first delivery module in fluid communication with the cell spheroids or organoid forming module, the sector retained in an outer shell, the outer shell including a second delivery module, the second delivery module in fluid communication with the cell spheroids or organoid forming module; loading cells into the cell spheroids or organoid forming module; culturing the cells in the cell spheroids or organoid forming module to provide cell spheroids or organoids; loading a first therapeutic into the first delivery module; loading a second therapeutic into the second delivery module; and
determining the effect on cell spheroids or organoid function.

### Claim 19 (depends on 18)

The method of claim 18, wherein the second therapeutic is loaded concomitantly with the first therapeutic.

### Claim 20

(canceled)

### Claim 21

(canceled)

### Claim 22

(canceled)

### Claim 23 (depends on 1)

A method of screening at least one therapeutic, the method comprising:
selecting the microfluidic device of claim 1; loading cells into the loading well;
culturing the cells in the microwells to provide cell spheroids or organoids; loading a first therapeutic into the delivery port; and determining the effect on cell spheroids or organoid function.

### Claim 24 (depends on 23)

The method of claim 23 further comprising loading an ECM hydrogel into the loading well prior to loading the first therapeutic.

### Claim 25 (depends on 23)

The method of claim 23, further comprising loading a second therapeutic into the delivery port after the first therapeutic is loaded.
